Transcode Therapeutics, Inc. (RNAZ) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $10.52M | +12.9% |
| 2024 | $9.31M | +163.9% |
| 2023 | $3.53M | -18.8% |
| 2022 | $4.35M | +71.6% |
| 2021 | $2.53M | -43.2% |
| 2020 | $4.46M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $10.52M | +12.9% |
| 2024 | $9.31M | +163.9% |
| 2023 | $3.53M | -18.8% |
| 2022 | $4.35M | +71.6% |
| 2021 | $2.53M | -43.2% |
| 2020 | $4.46M | — |